COVID vaccine trial for kids on track
UMass Medical School’s principal site investigator for Moderna’s TeenCOVE and KidCOVE mRNA COVID-19 vaccine clinical trials said that trial sites […]
» Read moreSurvival for a baby born with a birth defect—otherwise known as a congenital anomaly—is a “post-code lottery”, according to scientists […] Cancer survivors ages 18 to 64 faced fewer financial barriers to health care after the Affordable Care Act was implemented […] Although cardiovascular disease is the main cause of illness among women in the U.S., certain conditions such as coronary microvascular […] A new way to target a mutant protein which can cause the deadliest of cancers in humans has been uncovered […] (HealthDay)—The use of certain classes of diabetes medications prior to severe COVID-19 infection is associated with lower mortality in patients […] A recent proof-of-concept study finds that a low-cost training program can reduce hazardous driving in older adults. Researchers hope the […] Skoltech researchers and their colleagues from Russia and the UK investigated the safety and efficacy of new chemistry in antisense […] Fresh on the heels of the U.S. Food and Drug Administration’s approval of the controversial Alzheimer’s drug Aduhelm, the maker […] Over the past two decades, targeted cancer therapies have changed the prognosis for thousands of patients. By targeting the specific […]
Survival for babies born with a birth defect—a ‘post-code lottery’
Financial barriers fell for some cancer survivors after Affordable Care Act
New markers for coronary microvascular disease identified
New treatment options for the deadliest of cancers
Medication type for diabetes may affect severe COVID-19 outcomes
Computer training program for seniors can reduce hazardous driving
New components for antisense gene therapy show promise in treating spinal muscular atrophy
Lilly to seek FDA approval for new Alzheimer’s drug
Targeted therapy for ‘undruggable’ lung cancer
